Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jun 10:15:1431389.
doi: 10.3389/fpsyt.2024.1431389. eCollection 2024.

Editorial: Down the rabbit hole - the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions

Affiliations
Editorial

Editorial: Down the rabbit hole - the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions

Leehe Peled-Avron et al. Front Psychiatry. .
No abstract available

Keywords: 5-MeO-DMT; depression; entheogen; mechanisms; mystical experience; virtual reality.

PubMed Disclaimer

Conflict of interest statement

Author AK was employed by company NLC Health Ventures. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Down the rabbit hole – the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions

References

    1. Sanches RF, de Lima Osório F, Dos Santos RG, Macedo LR, Maia-de-Oliveira JP, Wichert-Ana L, et al. . Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A SPECT study. J Clin Psychopharmacol. (2016) 36:77–81. doi: 10.1097/JCP.0000000000000436 - DOI - PubMed
    1. Carhart-Harris RL, Friston KJ. REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics. Pharmacol Rev. (2019) 71:316–44. doi: 10.1124/pr.118.017160 - DOI - PMC - PubMed
    1. Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, et al. . Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial. psychol Med. (2019) 49:655–63. doi: 10.1017/S0033291718001356 - DOI - PMC - PubMed
    1. Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, et al. . Trial of psilocybin versus escitalopram for depression. New Engl J Med. (2021) 384:1402–11. doi: 10.1056/NEJMoa2032994 - DOI - PubMed
    1. Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, et al. . Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry. (2021) 78:481–9. doi: 10.1001/jamapsychiatry.2020.3285 - DOI - PMC - PubMed

Publication types

LinkOut - more resources